Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002186025 | SCV002484990 | likely benign | Renal cell carcinoma | 2024-05-22 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV003493923 | SCV004243324 | likely benign | not specified | 2025-03-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV004779261 | SCV005390840 | uncertain significance | not provided | 2024-04-03 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge |
Myriad Genetics, |
RCV005248536 | SCV005897920 | likely benign | Papillary renal cell carcinoma type 1 | 2024-11-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |